1. Home
  2. RAPP vs INNV Comparison

RAPP vs INNV Comparison

Compare RAPP & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$28.59

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Logo InnovAge Holding Corp.

INNV

InnovAge Holding Corp.

HOLD

Current Price

$8.89

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAPP
INNV
Founded
2022
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
RAPP
INNV
Price
$28.59
$8.89
Analyst Decision
Strong Buy
Sell
Analyst Count
6
1
Target Price
$48.50
$7.00
AVG Volume (30 Days)
318.5K
325.8K
Earning Date
01-01-0001
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
24.34
N/A
EPS
N/A
0.14
Revenue
N/A
$853,699,000.00
Revenue This Year
N/A
$12.85
Revenue Next Year
N/A
$8.88
P/E Ratio
N/A
$59.89
Revenue Growth
N/A
11.76
52 Week Low
$7.73
$2.60
52 Week High
$42.27
$10.69

Technical Indicators

Market Signals
Indicator
RAPP
INNV
Relative Strength Index (RSI) 48.89 55.15
Support Level $26.67 $5.01
Resistance Level $29.84 $9.18
Average True Range (ATR) 1.98 0.65
MACD -0.17 -0.19
Stochastic Oscillator 42.40 27.17

Price Performance

Historical Comparison
RAPP
INNV

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

About INNV InnovAge Holding Corp.

InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.

Share on Social Networks: